These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 32255283)
1. MiRNA-30 Play an Important Role in Non-Small Cell Lung Cancer (NSCLC). Sui JYAX Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255283 [TBL] [Abstract][Full Text] [Related]
2. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer. Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230 [TBL] [Abstract][Full Text] [Related]
3. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer. Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197 [TBL] [Abstract][Full Text] [Related]
4. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer. Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897 [TBL] [Abstract][Full Text] [Related]
5. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Liu XG; Zhu WY; Huang YY; Ma LN; Zhou SQ; Wang YK; Zeng F; Zhou JH; Zhang YK Med Oncol; 2012 Jun; 29(2):618-26. PubMed ID: 21516486 [TBL] [Abstract][Full Text] [Related]
6. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer. Hetta HF; Zahran AM; El-Mahdy RI; Nabil EE; Esmaeel HM; Elkady OA; Elkady A; Mohareb DA; Mahmoud Mostafa M; John J Asian Pac J Cancer Prev; 2019 Jun; 20(6):1927-1933. PubMed ID: 31244320 [TBL] [Abstract][Full Text] [Related]
7. The expression and clinical significance of miRNA-99a and miRNA-224 in non-small cell lung cancer. Yan HZ; Wang W; Du X; Jiang XD; Lin CY; Guo JL; Zhang J Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1545-1552. PubMed ID: 30840277 [TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108 [TBL] [Abstract][Full Text] [Related]
9. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients. Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752 [TBL] [Abstract][Full Text] [Related]
10. Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer. Hetta HF; Zahran AM; Shafik EA; El-Mahdy RI; Mohamed NA; Nabil EE; Esmaeel HM; Alkady OA; Elkady A; Mohareb DA; Hosni A; Mostafa MM; Elkady A Microrna; 2019; 8(3):206-215. PubMed ID: 30652656 [TBL] [Abstract][Full Text] [Related]
11. Expression and clinical significance of miR-139-5p in non-small cell lung cancer. Yong-Hao Y; Xian-Guo W; Ming X; Jin-Ping Z J Int Med Res; 2019 Feb; 47(2):867-874. PubMed ID: 30614351 [TBL] [Abstract][Full Text] [Related]
12. A Five-miRNA Panel Identified From a Multicentric Case-control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer Patients. Wang C; Ding M; Xia M; Chen S; Van Le A; Soto-Gil R; Shen Y; Wang N; Wang J; Gu W; Wang X; Zhang Y; Zen K; Chen X; Zhang C; Zhang CY EBioMedicine; 2015 Oct; 2(10):1377-85. PubMed ID: 26629532 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer. Su K; Zhang T; Wang Y; Hao G World J Surg Oncol; 2016 Aug; 14(1):224. PubMed ID: 27733164 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of serum miR-25 in non-small-cell lung cancer. Li J; Yu M; Liu Z; Liu B Br J Biomed Sci; 2019 Jul; 76(3):111-116. PubMed ID: 30919763 [No Abstract] [Full Text] [Related]
15. Prognostic value of microRNA-10b overexpression in peripheral blood mononuclear cells of nonsmall-cell lung cancer patients. Yang YL; Xu LP; Zhuo FL; Wang TY Tumour Biol; 2015 Sep; 36(9):7069-75. PubMed ID: 25869877 [TBL] [Abstract][Full Text] [Related]
16. Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer. Zhu W; He J; Chen D; Zhang B; Xu L; Ma H; Liu X; Zhang Y; Le H PLoS One; 2014; 9(2):e87780. PubMed ID: 24523873 [TBL] [Abstract][Full Text] [Related]
17. [Expression of MiRNA-221 in non-small cell lung cancer tissues and correlation with prognosis]. Lv J; Xu L; Xu Y; Qiu M; Yang X; Wang J; Yin R; Xu L Zhongguo Fei Ai Za Zhi; 2014 Mar; 17(3):221-5. PubMed ID: 24667259 [TBL] [Abstract][Full Text] [Related]
18. Serum miR-185 Is a Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer. Liu J; Han Y; Liu X; Wei S Technol Cancer Res Treat; 2020; 19():1533033820973276. PubMed ID: 33251978 [TBL] [Abstract][Full Text] [Related]
19. Increased Plasma miRNA-30a as a Biomarker for Non-Small Cell Lung Cancer. Sun L; Chen Y; Su Q; Tang X; Liang Y; Che G; Luo F Med Sci Monit; 2016 Feb; 22():647-55. PubMed ID: 26918265 [TBL] [Abstract][Full Text] [Related]
20. A predictive model for prognostic risk stratification of early-stage NSCLC based on clinicopathological and miRNA panel. Ying L; Lu T; Tian Y; Guo H; Wu C; Xu C; Jin J; Zhu R; Liu P; Yang Y; Yang C; Ding W; Xu C; Huang M; Ma Z; Zhang Y; Zhuo Y; Zou R; Su D Lung Cancer; 2024 Sep; 195():107902. PubMed ID: 39126888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]